Postmenopausal women on estrogen replacement were found to have reduced (epinephrine, muscle sympathetic nerve activity, pancreatic polypeptide, glucagon, endogenous glucose production, lactate, and glycerol) counterregulatory responses to hypoglycemia as compared to the similarly increased responses in women who were not on the replacement therapy and men. Here, GCG is linked to Hypoglycemia.